KC

Kevin X. Chen

SC Schering: 22 patents #97 of 2,442Top 4%
Merck: 11 patents #1,033 of 9,382Top 15%
MD Medshine Discovery: 7 patents #7 of 162Top 5%
Genentech: 6 patents #494 of 2,392Top 25%
DE Dendreon: 5 patents #26 of 92Top 30%
GC Guangdong Raynovent Biotech Co.: 4 patents #8 of 39Top 25%
CC Chia Tai Tianqing Pharmaceutical Group Co.: 3 patents #60 of 370Top 20%
CP Constellation Pharmaceuticals: 3 patents #35 of 60Top 60%
SC Shandong Luoxin Pharmaceutical Group Stock Co.: 1 patents #13 of 29Top 45%
LC Luoxin Pharmaceutical (Shanghai) Co.: 1 patents #9 of 19Top 50%
CC Cstone Pharmaceuticals (Suzhou) Co.: 1 patents #6 of 32Top 20%
CC Cstone Pharmaceuticals (Shanghai) Co.: 1 patents #6 of 32Top 20%
CP Cstone Pharmaceuticals: 1 patents #6 of 35Top 20%
📍 Shanghai, NJ: #8 of 137 inventorsTop 6%
Overall (All Time): #46,994 of 4,157,543Top 2%
54
Patents All Time

Issued Patents All Time

Showing 51–54 of 54 patents

Patent #TitleCo-InventorsDate
6914122 Macrocyclic NS-3 serine protease inhibitors of hepatitis C virus comprising alkyl and aryl alanine P2 moieties Srikanth Venkatraman, Ashok Arasappan, F. George Njoroge, Viyyoor M. Girijavallabhan, Ashit K. Ganguly +5 more 2005-07-05
6911428 Diaryl peptides as NS3-serine protease inhibitors of hepatitis C virus Zhaoning Zhu, Zhong-Yue Sun, Srikanth Venkatraman, F. George Njoroge, Ashok Arasappan +3 more 2005-06-28
6894072 Compounds as NS3-serine protease inhibitors of hepatitis C virus Ashok Arasappan, Frank Bennett, Stephane L. Bogen, Edwin Jao, Yi Liu +8 more 2005-05-17
6846802 Macrocyclic NS3-serine protease inhibitors of hepatitis C virus comprising N-cyclic P2 moieties Ashok Arasappan, Srikanth Venkatraman, Tejal Parekh, Haining Gu, George F. Njoroge +8 more 2005-01-25